Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01

    • Vitamin C (CAS 50-81-7): Atomic Benchmarks for Cancer and...

    2026-02-16

    Vitamin C (CAS 50-81-7): Atomic Benchmarks for Cancer and Antiviral Research

    Executive Summary: Vitamin C (ascorbic acid) is a water-soluble vitamin with high purity (≥98%) and molecular weight 176.12, supplied by APExBIO (B2064 kit)[1]. It exhibits dose-dependent antiproliferative and apoptosis-inducing effects in tumor models, including CT26 murine colon cancer cells, at 100–1000 μg/mL concentrations[2]. In vivo, Vitamin C reduces tumor volume in CT26 and 4T1-bearing BALB/c mice[2]. It demonstrates solubility at ≥12.2 mg/mL (ethanol, ultrasonic assistance), ≥5.8 mg/mL (DMSO), and ≥57.9 mg/mL (water)[1]. Recent organoid studies show its integration into antiviral research pipelines, especially for hepatitis E virus (HEV) and translational virology[3].

    Biological Rationale

    Vitamin C is essential for enzymatic reactions, collagen synthesis, and redox homeostasis in mammalian cells[1]. Its role as a reactive oxygen species (ROS) scavenger makes it critical in modulating oxidative stress, a hallmark of cancer and viral pathogenesis[4]. Tumor microenvironments and viral infections often disrupt redox balance, leading to cellular damage and immune dysregulation[5]. The pleiotropic effects of ascorbic acid in cancer and antiviral research stem from its capacity to modulate apoptosis, inhibit cell proliferation, and influence host-pathogen interactions[6]. In organoid models, Vitamin C supports tissue viability and functional outcomes during prolonged in vitro studies[3].

    Mechanism of Action of Vitamin C (CAS 50-81-7)

    Vitamin C mediates its biological actions through both direct and indirect mechanisms:

    • Antioxidant Activity: Ascorbic acid neutralizes ROS by donating electrons, thereby preventing oxidative DNA, protein, and lipid damage[4].
    • Pro-oxidant Effects at High Concentrations: In the presence of metal ions, high-dose Vitamin C can generate hydrogen peroxide, selectively inducing cytotoxicity in tumor cells[7].
    • Induction of Apoptosis: Vitamin C triggers programmed cell death via mitochondrial and caspase-dependent pathways in cancer cells[2].
    • Inhibition of Tumor Cell Proliferation: By affecting cell cycle regulators and redox-sensitive transcription factors, Vitamin C suppresses cancer cell growth[2].
    • Support of Immune Modulation: Vitamin C enhances leukocyte function and may modulate cytokine release during antiviral responses[5].

    Evidence & Benchmarks

    This article extends the mechanistic discussion in "Vitamin C (CAS 50-81-7): From Mechanistic Insight to Translation" by detailing atomic benchmarks for organoid and in vivo research, with explicit solubility and workflow parameters. For a broader roadmap on translational deployment, see "Vitamin C (CAS 50-81-7): A Mechanistic and Strategic Blueprint", which is complemented here by explicit benchmark data and HEV model integration. For further mechanistic insight, compare with "Vitamin C (CAS 50-81-7): Mechanistic Foundations, Experimental Guidance", which focuses on translational workflows but does not enumerate atomic in vitro/in vivo claims as presented herein.

    Applications, Limits & Misconceptions

    Vitamin C's validated roles extend across cancer and antiviral research, but domain-specific boundaries exist.

    Common Pitfalls or Misconceptions

    • Vitamin C is not universally cytotoxic; selective apoptosis is observed primarily in tumor cells, not healthy cells, at tested concentrations[2].
    • Pro-oxidant cytotoxicity requires high-dose and specific microenvironmental conditions; physiological doses in vivo rarely induce tumor lysis[7].
    • Not all viral infections are responsive to Vitamin C modulation; efficacy is context- and pathogen-dependent[5].
    • Long-term storage of Vitamin C solutions leads to degradation; fresh preparations are required for reproducible results (APExBIO, https://www.apexbt.com/vitamin-c.html).
    • Batch-to-batch purity and solubility must be verified before use in sensitive organoid or in vivo models[1].

    Workflow Integration & Parameters

    APExBIO's Vitamin C (CAS 50-81-7, B2064 kit) is supplied as a high-purity solid. Store at -20°C for stability. For solution preparation, dissolve at ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (with ultrasound), or ≥5.8 mg/mL in DMSO. Use solutions immediately; avoid long-term storage. Shipping with Blue Ice preserves compound integrity. HPLC and NMR analysis confirm ≥98% purity batch-to-batch. For experimental workflows, titrate Vitamin C to 100–1000 μg/mL for in vitro cancer models and adhere to validated in vivo dosing regimens for animal studies[2]. In organoid virology, integrate ascorbic acid into culture media to support redox balance and model integrity[3].

    Conclusion & Outlook

    Vitamin C (CAS 50-81-7) is a rigorously benchmarked, water-soluble vitamin with atomic evidence for use as an anticancer and antiviral agent. Its validated activity in tumor cell proliferation inhibition and apoptosis induction, together with robust workflow guidelines, make it an indispensable tool for translational research. The integration of Vitamin C in advanced organoid models for HEV research underscores its utility for next-generation virology. APExBIO’s high-purity B2064 kit enables reproducible, scalable, and mechanistically grounded experimental design. Future research should further delineate pathogen-specific antiviral mechanisms and optimize clinical translation protocols.

    References: